Concepedia

Tongguo Si

TS

5

Publications

194

Citations

5

H-Index

2021

Active since

Affiliations

Tianjin Medical University Cancer Institute and Hospital(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Chinese PLA General Hospital

Tsinghua University

Peking University

Tongguo Si is an author at Tianjin Medical University Cancer Institute and Hospital specializing in cancer research, medicine, and radiation oncology.

Top concepts

Publications per year

2021–2023

5

Publications

5

The Efficacy of TACE Combined With Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study

Fei Cao, Yi Yang, Tongguo Si et al. · Frontiers in Oncology · 2021 · 82 citations · Full text

Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations

Ming Zhao, Zhi Guo, Yinghua Zou et al. · Hepatology International · 2023 · 46 citations

, , +5

Hepatic arterial infusion chemotherapy combined with anti-PD-1/PD-L1 immunotherapy and molecularly targeted agents for advanced hepatocellular carcinoma: a real world study

Weihao Zhang, Kai Zhang, Changfu Liu et al. · Frontiers in Immunology · 2023 · 45 citations · Full text

Molecular characterization of<scp><i>MET</i></scp>fusions from a large real‐world Chinese population: A multicenter study

Hui Xia, Junhua Zhang, Tong Chen et al. · Cancer Medicine · 2023 · 11 citations · Full text

Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study

Bowen Chen, Linzhi Zhang, Jiamin Cheng et al. · Drug Design Development and Therapy · 2022 · 10 citations · Full text

Rows per page

1–5 of 5